2 results
Approved WMOPending
The objective of this clinical study is to prove the safety of the CorNeat KPro.
Approved WMOCompleted
The purpose of this study is to analyse the effect on pain reduction of butylscopolamine in a continuous intravenous infusion compared to a placebo in patients with renal colics not responding to oral NSAIDs.